280 related articles for article (PubMed ID: 11583151)
21. Kunitz domain inhibitors of tissue factor-factor VIIa. II. Potent and specific inhibitors by competitive phage selection.
Dennis MS; Lazarus RA
J Biol Chem; 1994 Sep; 269(35):22137-44. PubMed ID: 8071338
[TBL] [Abstract][Full Text] [Related]
22. Structural modulation of factor VIIa by full-length tissue factor (TF
Prasad R; Sen P
J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
[TBL] [Abstract][Full Text] [Related]
23. Macromolecular substrate affinity for free factor VIIa is independent of a buried protease domain N-terminus.
Persson E
Biochem Biophys Res Commun; 2006 Mar; 341(1):28-32. PubMed ID: 16406236
[TBL] [Abstract][Full Text] [Related]
24. Factor VII mutant V154G models a zymogen-like form of factor VIIa.
Toso R; Bernardi F; Tidd T; Pinotti M; Camire RM; Marchetti G; High KA; Pollak ES
Biochem J; 2003 Feb; 369(Pt 3):563-71. PubMed ID: 12358603
[TBL] [Abstract][Full Text] [Related]
25. Tissue Factor Residues That Modulate Magnesium-Dependent Rate Enhancements of the Tissue Factor/Factor VIIa Complex.
Gajsiewicz JM; Nuzzio KM; Rienstra CM; Morrissey JH
Biochemistry; 2015 Aug; 54(30):4665-71. PubMed ID: 26169722
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
27. Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.
Sorensen AB; Tuneew I; Svensson LA; Persson E; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
J Biol Chem; 2020 Jan; 295(2):517-528. PubMed ID: 31801825
[TBL] [Abstract][Full Text] [Related]
28. Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X.
Huang Q; Neuenschwander PF; Rezaie AR; Morrissey JH
J Biol Chem; 1996 Sep; 271(36):21752-7. PubMed ID: 8702971
[TBL] [Abstract][Full Text] [Related]
29. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
Olsen OH; Nielsen PF; Persson E
Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
[TBL] [Abstract][Full Text] [Related]
30. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
31. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
32. Model of a ternary complex between activated factor VII, tissue factor and factor IX.
Chen SW; Pellequer JL; Schved JF; Giansily-Blaizot M
Thromb Haemost; 2002 Jul; 88(1):74-82. PubMed ID: 12152682
[TBL] [Abstract][Full Text] [Related]
33. A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo.
Olivero AG; Eigenbrot C; Goldsmith R; Robarge K; Artis DR; Flygare J; Rawson T; Sutherlin DP; Kadkhodayan S; Beresini M; Elliott LO; DeGuzman GG; Banner DW; Ultsch M; Marzec U; Hanson SR; Refino C; Bunting S; Kirchhofer D
J Biol Chem; 2005 Mar; 280(10):9160-9. PubMed ID: 15632123
[TBL] [Abstract][Full Text] [Related]
34. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
35. Substitution of valine for leucine 305 in factor VIIa increases the intrinsic enzymatic activity.
Persson E; Bak H; Olsen OH
J Biol Chem; 2001 Aug; 276(31):29195-9. PubMed ID: 11389142
[TBL] [Abstract][Full Text] [Related]
36. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
Prasad R; Sen P
Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
[TBL] [Abstract][Full Text] [Related]
37. Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor.
Kadono S; Sakamoto A; Kikuchi Y; Oh-Eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
Biochem Biophys Res Commun; 2005 Jan; 326(4):859-65. PubMed ID: 15607748
[TBL] [Abstract][Full Text] [Related]
38. Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa.
Martínez-Martínez I; Ordóñez A; Pedersen S; de la Morena-Barrio ME; Navarro-Fernández J; Kristensen SR; Miñano A; Padilla J; Vicente V; Corral J
Thromb Res; 2011 Feb; 127(2):154-60. PubMed ID: 21126754
[TBL] [Abstract][Full Text] [Related]
39. The factor VII zymogen structure reveals reregistration of beta strands during activation.
Eigenbrot C; Kirchhofer D; Dennis MS; Santell L; Lazarus RA; Stamos J; Ultsch MH
Structure; 2001 Jul; 9(7):627-36. PubMed ID: 11470437
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding.
Kelley RF; Costas KE; O'Connell MP; Lazarus RA
Biochemistry; 1995 Aug; 34(33):10383-92. PubMed ID: 7654692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
